San Antonio breast cancer symposium--32nd annual meeting.
The 32nd San Antonio Breast Cancer Symposium, held in San Antonio, TX, USA, included topics covering etiology, epidemiology and tumor immunotherapy in the field of breast cancer therapy. This conference report discusses epigenetics and the PI3K/Akt/mTOR pathway in breast tumorigenesis.
Oesterreich
Steffi
S
Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. steffio@bcm.edu
D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D044127:Epigenesis, Genetic; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases
D047908:Intracellular Signaling Peptides and Proteins; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases; C546842:MTOR protein, human